JP2014028787A5 - - Google Patents

Download PDF

Info

Publication number
JP2014028787A5
JP2014028787A5 JP2012199657A JP2012199657A JP2014028787A5 JP 2014028787 A5 JP2014028787 A5 JP 2014028787A5 JP 2012199657 A JP2012199657 A JP 2012199657A JP 2012199657 A JP2012199657 A JP 2012199657A JP 2014028787 A5 JP2014028787 A5 JP 2014028787A5
Authority
JP
Japan
Prior art keywords
keratinocytes
whitening agent
integrin
whitening
action
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012199657A
Other languages
English (en)
Japanese (ja)
Other versions
JP6113981B2 (ja
JP2014028787A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012199657A priority Critical patent/JP6113981B2/ja
Priority claimed from JP2012199657A external-priority patent/JP6113981B2/ja
Publication of JP2014028787A publication Critical patent/JP2014028787A/ja
Publication of JP2014028787A5 publication Critical patent/JP2014028787A5/ja
Application granted granted Critical
Publication of JP6113981B2 publication Critical patent/JP6113981B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012199657A 2012-06-29 2012-09-11 スクリ−ニング方法 Active JP6113981B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012199657A JP6113981B2 (ja) 2012-06-29 2012-09-11 スクリ−ニング方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2012146197 2012-06-29
JP2012146197 2012-06-29
JP2012199657A JP6113981B2 (ja) 2012-06-29 2012-09-11 スクリ−ニング方法

Publications (3)

Publication Number Publication Date
JP2014028787A JP2014028787A (ja) 2014-02-13
JP2014028787A5 true JP2014028787A5 (cg-RX-API-DMAC10.html) 2015-06-25
JP6113981B2 JP6113981B2 (ja) 2017-04-12

Family

ID=50201648

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012199657A Active JP6113981B2 (ja) 2012-06-29 2012-09-11 スクリ−ニング方法

Country Status (1)

Country Link
JP (1) JP6113981B2 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6763497B1 (ja) * 2020-03-25 2020-09-30 大正製薬株式会社 ミネラル代謝異常抑制剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2375565T3 (es) * 2003-08-07 2012-03-02 Healor Ltd. Composiciones farmacéuticas y métodos para acelerar la cicatrización de heridas.
JPWO2005056751A1 (ja) * 2003-12-12 2007-07-05 株式会社日立メディコ 幹細胞の濃縮装置及び濃縮方法
JP5014569B2 (ja) * 2004-09-16 2012-08-29 オリザ油化株式会社 美肌用組成物
JP2008127357A (ja) * 2006-11-22 2008-06-05 Konan Kako Kk 皮膚外用剤組成物
JP5787285B2 (ja) * 2010-09-06 2015-09-30 公立大学法人大阪市立大学 線維芽細胞増殖促進剤、角化細胞遊走・増殖促進剤、エラスチン産生促進剤、ヒートショックタンパク質４７産生促進剤、α−平滑筋アクチン（α−ＳＭＡ）産生促進剤、及び光老化防止剤。

Similar Documents

Publication Publication Date Title
Castro et al. Ceramide: a simple sphingolipid with unique biophysical properties
FR2964565B1 (fr) Composition cosmetique comprenant un polymere fixant et un agent antipelliculaire
FR2962043B1 (fr) Composition cosmetique comprenant du peba
MX2015014892A (es) Metodo para un ensayo de deteccion de farmacos basado en celulas y el uso del mismo.
JP2011037847A5 (cg-RX-API-DMAC10.html)
JP2012140442A5 (cg-RX-API-DMAC10.html)
CL2014003110A1 (es) Anticuerpo anti-fcrn; secuencias que lo codifican; vector; célula huésped; proceso de producción; composición farmacéutica que lo comprende; uso para el tratamiento de enfermedad autoinmune; y ensayo para probar la capacidad de un anticuerpo para bloquear la actividad de fcrn humano.
PH12013500336A1 (en) Peptide or peptide complex binding to alpha2 integrin and methods and uses involving the same
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2014058976A3 (en) Biomarkers predictive for clinical response for glatiramer acetate
WO2013011294A3 (en) Diagnosis of alzheimer's disease
EP2803681A4 (en) VINYL ALCOHOL POLYMER AND METHOD OF MANUFACTURING THEREOF, AND COMPOSITION AND COATING WITH POLYVINYL ALCOHOL
FI3204767T3 (fi) Proteiinin hyödyllisyys in vivo -vaikutusten ennustamisessa
CL2013000756A1 (es) Forma cristalaina del citrato diacido de (4s)-4-(5-fenil-1,3,4-tiadiazol-2-iloxi)-1-azatriciclo[3.3.1.13,7]decano; proceso de preparacion; composicion farmaceutica; y su uso para tratar o prevenir un trastorno de la memoria, un trastorno cognitivo, neurodegeneracion, entre otros.
JP2012502289A5 (cg-RX-API-DMAC10.html)
JP2012527245A5 (cg-RX-API-DMAC10.html)
BR112012033177A2 (pt) método, aparelho, meio de armazenamento legível por computador transportando uma ou mais sequências de uma ou mais instruções e produto de programa de computador
EP2567233A4 (en) METHODS AND KITS FOR DETERMINING THE MULTIRESISTANCE OF CELLS TO MEDICINES
JP2015508790A5 (cg-RX-API-DMAC10.html)
WO2012077898A3 (ko) 대사질환과 연관된 후각수용체 유전자 및 그의 용도
JP2015180198A5 (cg-RX-API-DMAC10.html)
WO2014177867A3 (en) Differentially expressed biomarkers for alzheimer's disease
WO2012042062A3 (de) Markersequenzen für multiple sklerose und deren verwendung
HK1223129A1 (zh) 基因表现生物标记及其於潜在需要组蛋白去乙醯酶抑制剂治疗的患者的诊断和预後应用中的使用
JP2013503602A5 (cg-RX-API-DMAC10.html)